Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection

Frontiers in Cellular Neuroscience

Volumn , Issue DEC, 2012, Pages

  Munemasa, Yasunari ^a   Kitaoka, Yasushi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENDOTHELIN 1; ERYTHROPOIETIN; GLUTAMIC ACID; MITOCHONDRIAL PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; OPTIC ATROPHY TYPE 1 PROTEIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; THIOREDOXIN 1; THIOREDOXIN 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AGING; AUTOIMMUNITY; AXONAL INJURY; CELL ACTIVATION; CELL PROTECTION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; ELECTROPORATION; ENDOPLASMIC RETICULUM STRESS; EXCITOTOXICITY; GENE THERAPY; GLAUCOMA; GLAUCOMATOUS OPTIC NEUROPATHY; GLIA CELL; HUMAN; IMMUNOREGULATION; INTRAOCULAR PRESSURE ABNORMALITY; LAMINAR FLOW; MITOCHONDRION DEGENERATION; MOLECULAR PATHOLOGY; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; OPTIC NEURITIS; OXIDATIVE STRESS; PERIKARYON; RETINA DEGENERATION; RETINA GANGLION CELL; REVIEW; SECONDARY RETINA DEGENERATION;

EID: 84871558793     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2012.00060     Document Type: Review

References (171)

1. Acland, G.M., Aguirre, G.D., Ray, J., Zhang, Q., Aleman, T.S., Cideciyan, A.V., Pearce-Kelling, S.E., Anand, V., Zeng, Y., Maguire, A.M., Jacobson, S.G., Hauswirth, W.W., Bennett, J. (2001). Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. 28, 92-95.
2. Akagi, T., Hangai, M., Takayama, K., Nonaka, A., Ooto, S., Yoshimura, N. (2012). In vivo imaging of lamina cribrosa pores by adaptive optics scanning laser ophthalmoscopy. Invest. Ophthalmol. Vis. Sci. 53, 4111-4119.
3. Aktas, Z., Gurelik, G., Göçün, P.U., Akyürek, N., Onol, M., Hasanreisoǧlu, B. (2010). Matrix metalloproteinase-9 expression in retinal ganglion cell layer and effect of topically applied brimonidine tartrate 0.2% therapy on this expression in an endothelin-1-induced optic nerve ischemia model. Int. Ophthalmol. 30, 253-259.
4. Ali, R.R., Sarra, G.M., Stephens, C., Alwis, M.D., Bainbridge, J.W., Munro, P.M., Fauser, S., Reichel, M.B., Kinnon, C., Hunt, D.M., Bhattacharya, S.S., Thrasher, A.J. (2000). Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat. Genet. 25, 306-310.
5. Almasieh, M., Lieven, C.J., Levin, L.A., di Polo, A. (2011). A cell-permeable phosphine-borane complex delays retinal ganglion cell death after axonal injury through activation of the prosurvival extracellular signal-regulated kinases 1/2 pathway. J. Neurochem. 118, 1075-1086.
6. Anderson, D.R. (1969). Ultrastructure of human and monkey lamina cribrosa and optic nerve head. Arch Ophthalmol. 82, 800-814.
7. Anderson, DR. (1970). Ultrastructure of the optic nerve head. Arch. Ophthalmol. 83, 63-73.
8. Araki, T., Sasaki, Y., Milbrandt, J., 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010-1013.
9. Atlante, A., Calissano, P., Bobba, A., Giannattasio, S., Marra, E., Passarella, S. (2001). Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497, 1-5.
10. Awai, M., Koga, T., Inomata, Y., Oyadomari, S., Gotoh, T., Mori, M., Tanihara, H. (2006). NMDA-induced retinal injury is mediated by an endoplasmic reticulum stress-related protein, CHOP/GADD153. J. Neurochem. 96, 43-52.
11. Bagayogo, I.P., Dreyfus, C.F. (2009). Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway. ASN Neuro. 1, e00001.
12. Bai, J., Nakamura, H., Kwon, Y.W., Hattori, I., Yamaguchi, Y., Kim, Y.C., Kondo, N., Oka, S., Ueda, S., Masutani, H., Yodoi, J. (2003). Critical roles of thioredoxin in nerve growth factormediated signal transduction and neurite outgrowth in PC12 cells. J. Neurosci. 23, 503-509.
13. Barber, S.C., Mead, R.J., Shaw, P.J. (2006). Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta. 1762, 1051-1067.
14. Bonni, A., Brunet, A., West, A.E., Datta, S.R., Takasu, M.A., Greenberg, M.E. (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and - independent mechanisms. Science 286, 1358-1362
15. Bosley, T.M., Hellani, A., Spaeth, G.L., Myers, J., Katz, L.J., Moster, M.R., Milcarek, B., Abu- Amero, K.K. (2011). Down-regulation of OPA1 in patients with primary open angle glaucoma. Mol. Vis. 27, 1074-9
16. Bretscher, P. (1992). The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today. 1992 13, 74-76.
17. Browne, S.E., and Beal, M.F. (2006). Oxidative damage in Huntington's disease pathogenesis. Antioxid. Redox. 8, 2061-2073.
18. Caprioli, J. (1997). Neuroprotection of the optic nerve in glaucoma. Acta Ophthalmol. Scand. 75, 364-367.
19. Carter-Dawson, L., Shen, F., Harwerth, R.S., Smith, E.L. 3rd, Crawford, M.L., Chuang, A. (1998). Glutamine immunoreactivity in Müller cells of monkey eyes with experimental glaucoma. Exp. Eye Res. 66, 537-545.
20. Cellerino, A., Carroll, P., Thoenen, H., Barde, Y.A. (1997). Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol. Cell. Neurosci. 9, 397-408.
21. Chauhan, BC. (2008). Endothelin and its potential role in glaucoma. Can. J. Ophthalmol. 43, 356-360.
22. Chen, Y.Q., Pan, W.H., Liu, J.H., Chen, M.M., Liu, C.M., Yeh, M.Y., Tsai, S.K., Young, M.S., Zhang, X.M., Chao, H.M., 2012. The effects and underlying mechanisms of S-allyl l-cysteine treatment of the retina after ischemia/reperfusion. J. Ocul. Pharmacol. Ther. 28, 110-117.
23. Chiu, K., Lam, T.T., Ying, Li. W.W., Caprioli, J., Kwong, J.M. (2005). Calpain and N-methyl-d aspartate (NMDA)-induced excitotoxicity in rat retinas. Brain Res. 1046, 207-215.
24. Chun, M.H., Ju, W.K., Kim, K.Y., Lee, M.Y., Hofmann, H.D., Kirsch, M., Oh, S.J. (2000). Upregulation of ciliary neurotrophic factor in reactive Müller cells in the rat retina following optic nerve transection. Brain Res. 868, 358-362.
25. Cipolat, S., Martins de Brito, O., Dal Zilio, B., Scorrano, L. (2004). OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. U S A. 101, 15927-15932.
26. Conforti, L., Fang, G., Beirowski, B., Wang, M.S., Sorci, L., Asress, S., Adalbert, R., Silva, A., Bridge, K., Huang, X.P., Magni, G., Glass, J.D., Coleman, M.P. (2007). NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell. Death. Differ. 14, 116-127.
27. Conforti, L., Janeckova, L., Wagner, D., Mazzola, F., Cialabrini, L., Di Stefano, M., Orsomando, G., Magni, G., Bendotti, C., Smyth, N., Coleman, M. (2011). Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. FEBS J. 278, 2666-2679.
28. Dai, X., Lercher, L.D., Clinton, P.M., Du, Y., Livingston, D.L., Vieira, C., Yang, L., Shen, M.M., Dreyfus, C.F. (2003). The trophic role of oligodendrocytes in the basal forebrain. J. Neurosci. 23, 5846-5853.
29. Dai, Y., Weinreb, R.N., Kim, K.Y., Nguyen, D., Park, S., Sun, X., Lindsey, J.D., Ellisman, M.H., Ju, W.K. (2011). Inducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive rats. Invest. Ophthalmol. Vis. Sci. 52, 2468-2476.
30. Danbolt, N.C. (2001). Glutamate uptake. Prog Neurobiol. 65, 1-105.
31. Delettre, C., Lenaers, G., Griffoin, J.M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., Astarie-Dequeker, C., Lasquellec, L., Arnaud, B., Ducommun, B., Kaplan, J., Hamel, C.P. (2000). Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26, 207-210.
32. DePina, A.S., Langford, G.M. (1999). Vesicle transport: the role of actin filaments and myosin motors. Microsc. Res. Tech. 15, 93-106.
33. Di Matteo, V., Esposito, E. (2003). Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Curr. Drug Targets C.N.S. Neurol. Disord. 2, 95-107
34. Dingledine, R., Borges, K., Bowie, D., Traynelis, S.F. (1999). The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61.
35. DiStefano, P.S., Friedman, B., Radziejewski, C., Alexander, C., Boland, P., Schick, C.M., Lindsay, R.M., Wiegand, S.J. (1992). The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 8, 983-993.
36. Doh, S.H., Kim, J.H., Lee, K.M., Park, H.Y., Park, C.K. (2010). Retinal ganglion cell death induced by endoplasmic reticulum stress in a chronic glaucoma model. Brain Res. 13, 158-166.
37. Dougherty, K.D., Dreyfus, C.F., Black, I.B. (2000). Brain-derived neurotrophic factor in astrocytes, oligodendrocytes and microglial macrophages after spinal cord injury. Neurobiol. Dis. 7, 574-585.
38. Dusart, I., Schwab, M.E. (1994). Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci. 6, 712-724.
39. Faden, A.I. (1996). Pharmacological treatment of central nervous system trauma. Pharmacol. Toxicol. 78, 12-17.
40. Finkbeiner, S., Tavazoie, S.F., Maloratsky, A., Jacobs, K.M., Harris, K.M., Greenberg, M.E. (1997). CREB: a major mediator of neuronal neurotrophin responses. Neuron 19, 1031-1047.
41. Fischer, A.J., Reh, T.A. (2001). Müller glia are a potential source of neural regeneration in the postnatal chicken retina. Nat. Neurosci. 4, 247-452.
42. Fischer, D., Heiduschka, P., Thanos, S. (2001). Lens-injury-stimulated axonal regeneration throughout the optic pathway of adult rats. Exp. Neurol. 172, 257-272.
43. Freeland, K., Boxer, L.M., Latchman, D.S. (2001). The cyclic AMP respose element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells. Brain Res. Mol. Brain Res. 92, 98-106.
44. Fujino, H., Kitaoka, Y., Hayashi, Y., Munemasa, Y., Takeda, H., Kumai, T., Kobayashi, S., Ueno, S. (2009). Axonal protection by brain-derived neurotrophic factor associated with CREB phosphorylation in tumor necrosis factor-α-induced optic nerve degeneration. Acta Neuropathol. 117, 75-84.
45. Gao, H., Qiao, X., Cantor, L.B., WuDunn, D. (2002). Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch. Ophthalmol. 120, 797-803.
46. Gao, Y., Deng, K., Hou, J., Bryson, J.B., Barco, A., Nikulina, E., Spencer, T., Mellado, W., Kandel, E.R., Filbin, M.T. (2004). Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron 44, 609-621.
47. Georgopoulos, G., Andreanos, D., Liokis, N., Papakonstantinou, D., Vergados, J., Theodossiadis, G. (1997). Risk factors in ocular hypertension. Eur. J. Ophthalmol. 7, 357-363.
48. Gilley, J., and Coleman, M.P. (2010). Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol. 8, e1000300.
49. Gordon, M.O., Beiser, J.A., Brandt, J.D., Heuer, D.K., Higginbotham, E.J., Johnson, C.A., Keltner, J.L., Miller, J.P., Parrish, R.K. 2nd, Wilson, M.R., Kass, M.A. (2002). The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120, 714-720; discussion 829-830.
50. Görlach, A., Klappa, P., Kietzmann, T. (2006). The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid. Redox Signal. 8, 1391-1418.
51. Gregerson, D.S. (1998). Immune privilege in the retina. Ocul. Immunol. Inflamm. 6, 257-267.
52. Guo, Y., Chen, X., Zhang, H., Li, N., Yang, X., Cheng, W., Zhao, K. (2012). Association of OPA1 Polymorphisms with NTG and HTG: A Meta-Analysis. PLoS One 7, e42387.
53. Harada, T., Harada, C., Nakamura, K., Quah, H.M., Okumura, A., Namekata, K., Saeki, T., Aihara, M., Yoshida, H., Mitani, A., Tanaka, K. (2007). The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J. Clin. Invest. 117, 1763-1770.
54. Harada, T., Harada, C., Watanabe, M., Inoue, Y., Sakagawa, T., Nakayama, N., Sasaki, S., Okuyama, S., Watase, K., Wada, K., Tanaka, K. (1998). Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc. Natl. Acad. Sci. U. S. A. 95, 4663-4666.
55. Harbin, T.S., Podos, S.M., Kolker, A.E., Becker, B. (1976). Visual field progression in openangle glaucoma patients presenting with monocular field loss. Trans. Sect. Ophthalmol. Am. Acad. Ophthalmol. Otolaryngol. 8, 253-257.
56. Harman, A., Abrahams, B., Moore S, Hoskins, R. (2000). Neuronal density in the human retinal ganglion cell layer from 16-77 years. Anat. Rec. 260, 124-131.
57. Harper, M.M., Grozdanic, S.D., Bilts, B., Kuehn, M.H., Zamzow, D., Buss, J.E., Kardon, R.H., Sakaguchi, D.S. (2011). Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes. Invest. Ophthalmol. Vis. Sci. 52, 4506-4515.
58. Hauben, E., Butovsky, O., Nevo, U., Yoles, E., Moalem, G., Agranov, E., Mor, F., Leibowitz-Amit, R., Pevsner, E., Akselrod, S., Neeman, M., Cohen, I.R., Schwartz, M. (2000). Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20, 6421-6230.
59. Hauk, T.G., Leibinger, M., Müller, A., Andreadaki, A., Knippschild, U., Fischer, D. (2010). Stimulation of axon regeneration in the mature optic nerve by intravitreal application of the tolllike receptor 2 agonist Pam3Cys. Invest. Ophthalmol. Vis. Sci. 51, 459-564.
60. He, S., Prasanna, G., Yorio, T. (2007). Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Invest. Ophthalmol. Vis. Sci. 48, 3737-3745.
61. Honjo, M., Tanihara, H., Kido, N., Inatani, M., Okazaki, K., Honda, Y. (2000). Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA- and kainic acidinduced neuronal death. Invest. Ophthalmol. Vis. Sci. 41, 552-560.
62. Inokuchi, Y., Nakajima, Y., Shimazawa, M., Kurita, T., Kubo, M., Saito, A., Sajiki, H., Kudo, T., Aihara, M., Imaizumi, K., Araie, M., Hara, H. (2009). Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death. Inves t. Ophthalmol. Vis. Sci. 50, 334-344.
63. Inokuchi, Y., Nakajima, Y., Shimazawa, M., Kurita, T., Kubo, M., Saito, A., Sajiki, H., Kudo, T., Aihara, M., Imaizumi, K., Araie, M., Hara, H. (2009). Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death. Invest. Ophthalmol. Vis. Sci. 50, 334-344.
64. Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger, R.H., Gassmann, M., Gearhart, J.D., Lawler, A.M., Yu, A.Y., Semenza, G.L. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12, 149-162.
65. Ju, W.K., Kim, K.Y., Angert, M., Duong-Polk, K.X., Lindsey, J.D., Ellisman, M.H., Weinreb, R.N. (2009). Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest. Ophthalmol. Vis. Sci. 50, 707-716.
66. Ju, W.K., Kim, K.Y., Lindsey, J.D., Angert, M., Duong-Polk, K.X., Scott, R.T., Kim, J.J., Kukhmazov, I., Ellisman, M.H., Perkins, G.A., Wenreb, R.N. (2008). Intraocular pressure elevation induces mitochondrial fission and triggers OPA1 release in glaucomatous optic nerve. Invest. Ophthalmol. Vis. Sci. 49, 4903-4911.
67. Ju, W.K., Lee, M.Y., Hofmann, H.D., Kirsch, M., Chun, M.H. (1999). Expression of CNTF in üller cells of the rat retina after pressure-induced ischemia. Neuroreport. 10, 419-422.
68. Kamalden, T.A., Ji, D., Osborne, N.N. (2012). Rotenone-induced death of RGC-5 cells is caspase independent, involves the JNK and p38 pathways and is attenuated by specific green tea flavonoids. Neurochem. Res. 37, 1091-1101.
69. Kanamori, A., Catrinescu, M.M., Kanamori, N., Mears, K.A., Beaubien, R., Levin, L.A. (2010). Superoxide is an associated signal for apoptosis in axonal injury. Brain. 33, 2612-2625.
70. Kawasaki, A., Otori, Y., Barnstable, C.J. (2000). Müller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity. Invest. Ophthalmol. Vis. Sci. 41, 3444-3450.
71. Kikuchi, M., Tenneti, L., Lipton, SA. (2000). Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J. Neurosci. 20, 5037-5044.
72. Kim, J.H., Lee, N.Y., Jung, S.W., Park, C.K. (2007). Expression of N-methyl-d-aspartate receptor 1 in rats with chronic ocular hypertension. Neuroscience. 149, 908-916.
73. Kipnis, J., Mizrahi, T., Yoles, E., Ben-Nun, A., Schwartz, M. (2002). Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. Neuroimmunol. 130, 78-85.
74. Kitaoka, Y., Hayashi, Y., Kumai, T., Takeda, H., Munemasa, Y., Fujino, H., Kitaoka, Y., Ueno, S., Sadun, A.A., Lam, T.T. (2009). Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy. J. Neuropathol. Exp. Neurol. 68, 915-927.
75. Kitaoka, Y., Kitaoka, Y., Kwong, J.M., Ross-Cisneros, F.N., Wang, J., Tsai, R.K., Sadun, A.A., Lam, T.T. (2006). TNF-α-induced optic nerve degeneration and nuclear factor-κB p65. Invest. Ophthalmol. Vis. Sci. 47, 1448-1457.
76. Kitaoka, Y., Kumai, T., Kitaoka, Y., Lam, T.T., Munemasa, Y., Isenoumi, K., Motoki, M., Kuribayashi, K., Kogo, J., Kobayashi, S., Ueno, S. (2004). Nuclear factor-kappa B p65 in NMDA-induced retinal neurotoxicity. Brain Res. Mol. Brain Res. 131, 8-16.
77. Kitaoka, Y., Munemasa, Y., Hayashi, Y., Kuribayashi, J., Koseki, N., Kojima, K., Kumai, T., Ueno, S. (2011). Axonal protection by 17β-estradiol through thioredoxin-1 in tumor necrosis factor-induced optic neuropathy. Endocrinology 152, 2775-2785.
78. Kitaoka, Y., Munemasa, Y., Nakazawa, T., Ueno, S. (2007). NMDA-induced interleukin-1beta expression is mediated by nuclear factor-kappa B p65 in the retina. Brain Res. 20, 247-255.
79. Kuribayashi, J., Kitaoka, Y., Munemasa, Y., Ueno, S. (2010). Kinesin-1 and degenerative changes in optic nerve axons in NMDA-induced neurotoxicity. Brain Res. 1362, 133-140.
80. Laabich, A., Li, G., Cooper, N.G. (2001). Characterization of apoptosis-genes associated with NMDA mediated cell death in the adult rat retina. Brain Res. Mol. Brain Res. 91, 34-42.
81. Lambert, W.S., Ruiz, L., Crish, S.D., Wheeler, L.A., Calkins, D.J. (2011). Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol. Neurodegener. 6, 4.
82. Laties, A.M., Nichols, C.W. (1971). Demonstration of a nonspecific cholinesterase in retinal Müller cell. Am. J. Ophthalmol. 71, 1093-1098.
83. Lau, J., Dang, M., Hockmann, K., Ball, A.K. (2006). Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat. Exp. Eye. Res. 82, 132-145.
84. Lee, S.Y., Andoh, T., Murphy, D.L., Chiueh, C.C. (2003). 17β-estradiol activates ICI182,780- sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection. FASEB J. 17, 947-948.
85. Leske, M.C., Heijl, A., Hussein, M., Bengtsson, B., Hyman, L., Komaroff, E. (2003). For the Early Manifest Glaucoma Trial Group, Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 121, 48-56.
86. Lieven, C.J., Schlieve, C.R., Hoegger, M.J., Levin, L.A. (2006). Retinal ganglion cell axotomy induces an increase in intracellular superoxide anion. Invest. Ophthalmol. Vis. Sci. 47, 1477-1485.
87. Lippoldt, A., Padilla, C.A., Gerst, H., Andbjer, B., Richter, E., Holmgren, A., Fuxe, K. (1995). Localization of thioredoxin in the rat brain and functional implications. J. Neurosci. 15, 6747-6756.
88. Liu D, McAdoo DJ. (1993). An experimental model combining microdialysis with electrophysiology, histology, and neurochemistry for exploring mechanisms of secondary damage in spinal cord injury: effects of potassium. J. Neurotrauma. 10, 349-362.
89. Lonze, B.E., and Ginty, D.D. (2002). Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623.
90. Luo, X.G., Chiu, K., Lau, F.H., Lee, V.W., Yung, K.K., So, K.F. (2009). The selective vulnerability of retinal ganglion cells in rat chronic ocular hypertension model at early phase. Cell. Mol. Neurobiol. 29, 1143-1151.
91. Mabuchi, F., Aihara, M., Mackey, M.R., Lindsey, J.D., Weinreb, R.N. (2003). Optic nerve damage in experimental mouse ocular hypertension. Invest. Ophthalmol. Vis. Sci. 44, 4321-4330
92. MacCumber, M.W., and D'Anna, S.A. (1994). Endothelin receptor-binding subtypes in the human retina and choroid. Arch. Ophthalmol. 112, 1231-1215.
93. Martin, K.R., Levkovitch-Verbin, H., Valenta, D., Baumrind, L., Pease, M.E., Quigley, H.A. (2002). Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest. Ophthalmol. Vis. Sci. 43, 2236-2243.
94. Martin, K.R., Quigley, H., Valenta, D., Kielczewski, J., Pease, M. (2006). Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp. Eye Res. 83, 255-262.
95. Matsui, K., Hosoi, N., Tachibana, M. (1999). Active role of glutamate uptake in the synaptic transmission from retinal nonspiking neurons. J. Neurosci. 19, 6755-6766.
96. May, C.A., and Mittag, T. (2006). Optic nerve degeneration in the DBA/2NNia mouse: is the lamina cribrosa important in the development of glaucomatous optic neuropathy? Acta Neuropathol. 111, 158-167.
97. McElnea, E.M., Quill, B., Docherty, N.G., Irnaten, M., Siah, W.F., Clark, A.F., O'Brien, C.J., Wallace, D.M. (2011). Oxidative stress, mitochondrial dysfunction and calcium overload in human lamina cribrosa cells from glaucoma donors. Mol. Vis. 17, 1182-1191.
98. McKerracher L., Vallee R.B., Aguayo A.J. (1989). Microtubule-associated protein 1A (MAP 1A) is a ganglion cell marker in adult rat retina. Vis. Neurosci. 2, 349-356.
99. Minton, A.Z., Phatak, N.R., Stankowska, D.L., He, S., Ma, H.Y., Mueller, B.H., Jiang, M., Luedtke, R., Yang, S., Brownlee, C., Krishnamoorthy, R.R. (2012). Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma. PLoS One. 7, e43199.
100. Moreno, M., Campanelli, J., Sande, P., Snez, D., Keller-Sarmiento, M., Rosenstein, R. (2004). Retinal oxidative stress induced by high intraocular pressure. Free Radic. Biol. Med. 37, 803-812.
101. Morrison, J., Farrell, S., Johnson, E., Deppmeier, L., Moore, C.G., Grossmann, E. (1995). Structure and composition of the rodent lamina cribrosa. Exp. Eye. Res. 60, 127-135.
102. Morrison, J., Farrell, S., Johnson, E., Deppmeier, L., Moore, C.G., Grossmann, E. (1995). Structure and composition of the rodent lamina cribrosa. Exp. Eye. Res. 60, 127-135.
103. Morrison, J.C., Dorman-Pease, M.E., Dunkelberger, G.R., Quigley, H.A. (1990). Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma. Arch. Ophthalmol. 108, 1020-1024.
104. Munemasa, Y., Ahn, J.H., Kwong, J.M., Caprioli, J., Piri, N. (2009). Redox proteins thioredoxin1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther. 16, 17-25.
105. Munemasa, Y., Chang, C.S., Kwong, J.M., Kyung, H., Kitaoka, Y., Caprioli, J., Piri, N. (2012). The neuronal EGF-related gene Nell2 interacts with Macf1 and supports survival of retinal ganglion cells after optic nerve injury. PLoS One. 7, e34810.
106. Munemasa, Y., Kim, S.H., Ahn, J.H., Kwong, J.M.K., Caprioli, J., Piri, N. (2008). Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transaction and oxidative stress. Invest. Ophthalmol. Vis. Sci. 49, 3535-3543.
107. Munemasa, Y., Kitaoka, Y., Kuribayashi, J., Ueno, S. (2010). Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model. J. Neurochem. 115, 1508-1519.
108. Munemasa, Y., Ohtani-Kaneko, R., Kitaoka, Y., Kumai, T., Kitaoka, Y., Hayashi, Y., Watanabe, M., Takeda, H., Hirata, K., Ueno, S. (2006). Pro-apoptotic role of c-Jun in NMDA-induced neurotoxicity in the rat retina. J. Neurosci. Res. 83, 907-918.
109. Munemasa, Y., Ohtani-Kaneko, R., Kitaoka, Y., Kuribayashi, K., Isenoumi, K., Kogo, J., Yamashita, K., Kumai, T., Kobayashi, S., Hirata, K., Ueno, S. (2005). Contribution of mitogenactivated protein kinases to NMDA-induced neurotoxicity in the rat retina. Brain Res.1044, 227-240.
110. Nadeau, P.J., Charette, S.J., Toledano, M.B., Landry, J. (2007). Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis. Mol. Biol. Cell. 18, 3903-3913.
111. Nakazawa, T., Nakazawa, C., Matsubara, A., Noda, K., Hisatomi, T., She, H., Michaud, N., Hafezi-Moghadam, A., Miller, J.W., Benowitz, L.I. (2006). Tumor necrosis factor-α mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 26, 12633-12641.
112. Neufeld, A.H., Gachie, E.N. (2003). The inherent, age-dependent loss of retinal ganglion cells is related to the lifespan of the species. Neurobiol. Aging. 24, 167-172.
113. North, B.J., and Verdin, E. (2004). Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 5, 224.
114. Oku, H., Ikeda, T., Honma, Y., Sotozono, C., Nishida, K., Nakamura, Y., Kida, T., Kinoshita, S. (2002). Gene expression of neurotrophins and their high-affinity Trk receptors in cultured human Müller cells. Ophthalmic Res. 34, 38-42.
115. Pannicke, T., Uckermann, O., Iandiev, I., Biedermann, B., Wiedemann, P., Perlman, I., Reichenbach, A., Bringmann, A. (2005). Altered membrane physiology in Müller glial cells after transient ischemia of the rat retina. Glia. 50, 1-11.
116. Paulson, O.B., and Newman, E.A. (1987). Does the release of potassium from astrocyte endfeet regulate cerebral blood flow? Science 237, 896-898.
117. Peitsch, M.C., Müller, C., Tschopp, J. (1993). DNA fragmentation during apoptosis is caused by frequent single-strand cuts. Nucleic Acids Res. 21, 4206-4209.
118. Penfold, P.L., and Provis, J.M. (1986). Cell death in the development of the human retina: phagocytosis of pyknotic and apoptotic bodies by retinal cells. Graefes Arch. Clin. Exp. Ophthalmol. 224, 549-553.
119. Perge, J.A., Koch, K., Miller, R., Sterling, P., Balasubramanian, V. (2009). How the optic nerve allocates space, energy capacity, and information. J. Neurosci. 29, 7917-7928.
120. Poitry-Yamate, C.L., Poitry, S., Tsacopoulos, M. (1995). Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina. J. Neurosci. 15, 5179-5191.
121. Press, C., Milbrandt, J. (2008). Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J. Neurosci. 28, 4861-4871.
122. Quigley, H.A. (1996). Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80, 389-393.
123. Quigley, H.A., Addicks, E.M. (1980). Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci. 19, 137-152.
124. Quigley, H.A., Brown, A., Dorman-Pease, M.E. (1991). Alterations in elastin of the optic nerve head in human and experimental glaucoma. Br. J. Ophthalmol. 75, 552-557.
125. Quigley, H.A., Dorman-Pease, M.E., Brown, A.E. (1991). Quantitative study of collagen and elastin of the optic nerve head and sclera in human and experimental monkey glaucoma. Curr. Eye. Res. 10, 877-888
126. Quigley, H.A., McKinnon, S.J., Zack, D.J., Pease, M.E., Kerrigan-Baumrind, L.A., Kerrigan, D.F., Mitchell, R.S. (2000). Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 41, 3460-3466.
127. Repka, M.X., Quigley, H.A. (1989). The effect of age on normal human optic nerve fiber number and diameter. Ophthalmology. 96, 26-32.
128. Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I., Pararajasegaram, R., Pokharel, GP., Mariotti, S.P. (2004). Global data on visual impairment in the year 2002. Bull. World Health Organ. 82, 844-851.
129. Roh, M., Zhang, Y., Murakami, Y., Thanos, A., Lee, S.C., Vavvas, D.G., Benowitz, L.I., Miller, J.W. (2012). Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One 7, e40065.
130. Sarthy, V.P., Pignataro, L., Pannicke, T., Weick, M., Reichenbach, A., Harada, T., Tanaka, K., Marc, R. (2005). Glutamate transport by retinal Muller cells in glutamate/aspartate transporterknockout mice. Glia 49, 184-196.
131. Sato, T., Fujikado, T., Lee, T.S., Tano, Y. (2008). Direct effect of electrical stimulation on induction of brain-derived neurotrophic factor from cultured retinal Müller cells. Invest. Ophthalmol. Vis. Sci. 49, 4641-4646.
132. Savitt, J.M., Dawson, V.L., Dawson, T.M. (2006). Diagnosis and treatment of Parkinson disease: molecules to medicine. J. Clin. Invest. 116, 1744-1754.
133. Sawada, H., Fukuchi, T., Tanaka, T., Abe, H. (2010). Tumor necrosis factor-α concentrations in the aqueous humor of patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 51, 903-906.
134. Schori, H., Kipnis, J., Yoles, E., WoldeMussie, E., Ruiz, G., Wheeler, LA., Schwartz M. (2001). Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc. Natl. Acad. Sci. U. S. A. 98, 3398-3403.
135. Shimazawa, M., Ito, Y., Inokuchi, Y., Hara, H. (2007). Involvement of double-stranded RNAdependent protein kinase in ER stress-induced retinal neuron damage. Invest. Ophthalmol. Vis. Sci. 48, 3729-3736.
136. Shindler, K.S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D.C., Rostami, A. (2010). Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J. Neuroophthalmol. 30, 328-339.
137. Son, J.L., Soto, I., Oglesby, E., Lopez-Roca, T., Pease, M.E., Quigley, H.A., Marsh-Armstrong, N. (2010). Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 58, 780-789.
138. Spear, P.D. (1993). Neural bases of visual deficits during aging. Vision Res. 33, 2589-2609.
139. Stemme, S., Hansson, H.A., Holmgren, A., Rozell, B. (1985). Axoplasmic transport of thioredoxin and thioredoxin reductase in rat sciatic nerve. Brain Res. 359, 140-146.
140. Streilein, J.W., Okamoto, S., Sano, Y., Taylor, A.W. (2000). Neural control of ocular immune privilege. Ann. N. Y. Acad. Sci. 917, 297-306.
141. Sullivan, T.A., Geisert, E.E., Hines-Beard, J., Rex, T.S. (2011). Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA/2J glaucomatous mice. Hum. Gene. Ther. 22, 1191-1200.
142. Takada, K., Munemasa, Y., Kuribayashi, J., Fujino, H., Kitaoka, Y. (2011). Protective effect of thalidomide against N-methyl-D-aspartate-induced retinal neurotoxicity. J. Neurosci. Res. 89, 1596-1604.
143. Takeda, H., Kitaoka, Y., Hayashi, Y., Kumai, T., Munemasa, Y., Fujino, H., Kobayashi, S., Ueno, S. (2007). Calcium/calmodulin-dependent protein kinase II regulates the phosphorylation of CREB in NMDA-induced retinal neurotoxicity. Brain Res. 12, 1184:306-315.
144. Tao, X., Finkbeiner, S., Arnold, D.B., Shaywitz, A.J., Greenberg, M.E. (1998). Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709-726
145. Tezel, G. (2006). Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 25, 490-513.
146. Tezel, G., Li, L.Y., Patil, R.V., Wax, M.B. (2001). TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 42, 1787-1794.
147. Tezel, G., and Wax, M.B. (1999). Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest. Ophthalmol. Vis. Sci. 40, 2660-2667.
148. Tezel, G., and Wax, M.B. (2000). Increased production of tumor necrosis factor-α by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induced apoptosis in cocultured retinal ganglion cells. J. Neurosci. 20, 8693-8700.
149. Tezel, G., Yang, X., Luo, C., Cai, J., Powell, DW. (2012). An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma. Invest. Ophthalmol. Vis. Sci. 53, 4220-4233.
150. Tezel, G., and Wax, M.B. (2000). Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci. 20, 8693-8700.
151. Tielsch, J.M., Katz, J., Singh, K., Quigley, H.A., Gottsch, J.D., Javitt, J., Sommer, A. (1991). A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am. J. Epidemiol. 134, 1102-1110.
152. Tonari, M., Kurimoto, T., Horie, T., Sugiyama, T., Ikeda, T., Oku, H. (2012). Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation. Invest. Ophthalmol. Vis. Sci. 53, 3490-3500.
153. Tonge, D., Chan, K., Zhu, N., Panjwani, A., Arno, M., Lynham, S., Ward, M., Snape, A., Pizzey, J. (2008). Enhancement of axonal regeneration by in vitro conditioning and its inhibition by cyclopentenone prostaglandins. J. Cell. Sci. 121, 2565-2577.
154. Tsacopoulos, M., Magistretti, P.J. (1996). Metabolic coupling between glia and neurons. J. Neurosci. 16, 877-85.
155. Unterlauft, J.D., Eichler, W., Kuhne, K., Yang, X.M., Yafai, Y., Wiedemann, P., Reichenbach, A., Claudepierre, T. (2012). Pigment epithelium-derived factor released by Müller glial cells exerts neuroprotective effects on retinal ganglion cells. Neurochem. Res. 37, 1524-1533.
156. Van Bergen, N.J., Crowston, J.G., Kearns, L.S., Staffieri, S.E., Hewitt, A.W., Cohn, A.C., Mackey, D.A. (2011). Trounce IA.Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy. PLoS One 6, e21347.
157. VonDran, M.W., Singh, H., Honeywell, J.Z., Dreyfus, C.F. (2011). Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion. J. Neurosci. 31, 14182-14190.
158. Walton, M., Woodgate, A.M., Muravlev, A., Xu, R., During, M.J., Dragunow, M. (1999). CREB phosphorylation promotes nerve cell survival. J. Neurochem. 73, 1836-1842.
159. Wang, D., Masutani, H., Oka, S., Tanaka, T., Yamaguchi-Iwai, Y., Nakamura, H., Yodoi, J. (2006). Control of mitochondrial outer membrane permeabilization and Bcl-xL levels by thioredoxin 2 in DT40 cells. J. Biol. Chem. 281, 7384-91.
160. Wang, G.L., Jiang, B.H., Rue, E.A., Semenza, G.L. (1995). Hypoxia inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514.
161. Watson, F.L., Heerssen, H.M., Moheban, D.B., Lin, M.Z., Sauvageot, C.M., Bhattacharyya, A., Pomeroy, S.L., Segal, R.A. (1999). Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J. Neurosci. 19, 7889-7900.
162. Wax, M.B., Tezel, G., Yang, J., Peng, G., Patil, R.V., Agarwal, N., Sappington, R.M., Calkins, D.J. (2008). Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J. Neurosci. 28, 12085-12096.
163. Weber, A.J., Viswanáthan, S., Ramanathan, C., Harman, C.D. (2010). Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic erve injury. Invest. Ophthalmol. Vis. Sci. 51, 327-334.
164. Williams, P.A., Piechota, M., von Ruhland, C., Taylor, E., Morgan, J.E., Votruba, M. (2012). Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity. Brain 135, 493-505.
165. Yahata, N., Yuasa, S., Araki, T., 2009. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. J. Neurosci. 29, 6276-6284.
166. Yan, X., Tezel, G., Wax, M.B., Edward, D.P. (2000). Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch. Ophthalmol. 118, 666-678.
167. Yang, X., Luo, C., Cai, J., Powell, D.W., Yu, D., Kuehn, M.H., Tezel, G. (2011). Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina. Invest. Ophthalmol. Vis. Sci. 52, 8422-8454.
168. Yin, Y., Cui, Q., Li, Y., Irwin, N., Fischer, D., Harvey, A.R., Benowitz, L.I. Macrophagederived factors stimulate optic nerve regeneration. J. Neurosci. 23, 2284-2293.
169. Yuan, L., Neufeld, A.H. (2000). Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32, 42-50.
170. Yuan, L., and Neufeld, A.H. (2001). Activated microglia in the human glaucomatous optic nerve head. J. Neurosci. Res. 64, 523-532.
171. Yuki, K., Ozawa, Y., Yoshida, T., Kurihara, T., Hirasawa, M., Ozeki, N., Shiba, D., Noda, K., Ishida, S., Tsubota, K. (2011). Retinal ganglion cell loss in superoxide dismutase 1 deficiency. Invest. Ophthalmol. Vis. Sci. 52, 4143-4150.